Entrada Therapeutics Inc(TRDA)
$4.35-0.29 (-6.25%)
TRDA
Entrada Therapeutics Inc financials statements
$4.35
At close:-0.29 (-6.25%)
Want to see TRDA full AI Analyst Report?
Entrada Therapeutics Inc (TRDA) Income Statement
164 Followers
Entrada Therapeutics Inc Income Statement
Last quarter (Q3 2026), Entrada Therapeutics Inc's total revenue was $905.00K, a decrease of 43.93% from the same quarter last year. In Q3, Entrada Therapeutics Inc's net income was $-39.74M. See Entrada Therapeutics Inc’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 25.42M | $ 210.78M | $ 129.01M | $ 0.00 | $ 0.00 | |
| $ 21.32M | $ 210.78M | $ 129.01M | $ 0.00 | $ 0.00 | |
| $ 177.32M | $ 163.77M | $ 132.18M | $ 97.25M | $ 51.13M | |
| Depreciation and Amortization | $ 4.10M | $ 3.77M | $ 2.84M | $ 1.90M | $ 1.12M |
| $ -138.73M | $ 70.26M | $ 14.90M | $ -90.09M | $ -50.04M | |
| $ -156.00M | $ 47.01M | $ -3.16M | $ -97.25M | $ -51.13M | |
| $ 13.17M | $ 19.47M | $ 15.22M | $ 2.63M | $ -31.00K | |
| $ -142.83M | $ 66.48M | $ 12.06M | $ -94.62M | $ -51.16M | |
| $ -143.75M | $ 65.63M | $ -6.68M | $ -94.62M | $ -51.16M | |
| Per Share Metrics | |||||
| Basic EPS | $ -3.47 | $ 1.76 | $ -0.20 | $ -2.79 | $ -1.60 |
| Diluted EPS | $ -3.47 | $ 1.68 | $ -0.20 | $ -2.79 | $ -1.60 |
| Weighted Average Shares Outstanding | 41.37M | 37.31M | 33.05M | 31.29M | 31.22M |
| Weighted Average Shares Outstanding (Diluted) | 41.37M | 39.00M | 33.05M | 31.29M | 31.22M |
Currency in USD

